US Stock MarketDetailed Quotes
FRTX Fresh Tracks Therapeutics
- 0.910
- -0.010-1.14%
15min DelayClose Apr 26 16:00 ET
5.44MMarket Cap-858P/E (TTM)
0.921High0.910Low795Volume0.910Open0.921Pre Close726.54Turnover0.02%Turnover RatioLossP/E (Static)5.97MShares1.10052wk High0.55P/B4.52MFloat Cap0.45052wk Low--Dividend TTM4.96MShs Float23152.500Historical High--Div YieldTTM1.14%Amplitude0.450Historical Low0.913Avg Price1Lot Size
Fresh Tracks Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 25.21%10.87M | 25.21%10.87M | 6.84%12.02M | -38.20%8.95M | -37.74%10.76M | -67.71%8.68M | -67.71%8.68M | -47.39%11.25M | -40.68%14.48M | -50.29%17.29M |
| -Cash and cash equivalents | 25.21%10.87M | 25.21%10.87M | 6.84%12.02M | -38.20%8.95M | -37.74%10.76M | -67.71%8.68M | -67.71%8.68M | -47.39%11.25M | -40.68%14.48M | -50.29%17.29M |
| Receivables | -91.07%45K | -91.07%45K | --0 | -51.96%245K | 188.04%265K | 303.20%504K | 303.20%504K | --681K | --510K | --92K |
| -Accounts receivable | -82.00%45K | -82.00%45K | --0 | --0 | -51.09%45K | 100.00%250K | 100.00%250K | --372K | --358K | --92K |
| -Other receivables | ---- | ---- | ---- | 61.18%245K | --220K | --254K | --254K | --309K | --152K | ---- |
| Prepaid assets | -29.68%545K | -29.68%545K | -70.51%688K | -86.39%443K | -76.48%777K | -69.39%775K | -69.39%775K | -12.56%2.33M | -27.80%3.25M | -17.34%3.3M |
| Other current assets | -24.19%94K | -24.19%94K | 4,257.14%305K | 942.86%73K | -12.50%7K | 110.17%124K | 110.17%124K | --7K | --7K | --8K |
| Total current assets | 14.57%11.55M | 14.57%11.55M | -8.82%13.01M | -46.80%9.71M | -42.91%11.81M | -65.94%10.08M | -65.94%10.08M | -40.66%14.27M | -36.88%18.25M | -46.64%20.69M |
| Non current assets | ||||||||||
| Net PPE | -72.58%34K | -72.58%34K | -55.56%44K | -4.00%72K | -6.25%90K | 5.98%124K | 5.98%124K | -27.74%99K | -52.53%75K | 31.51%96K |
| -Gross PPE | -72.58%34K | -72.58%34K | -55.56%44K | -4.00%72K | -6.25%90K | 5.98%124K | 5.98%124K | -27.74%99K | -52.53%75K | --96K |
| Non current accounts receivable | ---- | ---- | ---- | -66.30%61K | --64K | --64K | --64K | --77K | --181K | ---- |
| Total non current assets | -81.91%34K | -81.91%34K | -75.00%44K | -48.05%133K | 60.42%154K | 60.68%188K | 60.68%188K | 28.47%176K | 62.03%256K | 31.51%96K |
| Total assets | 12.80%11.59M | 12.80%11.59M | -9.62%13.06M | -46.82%9.84M | -42.44%11.97M | -65.44%10.27M | -65.44%10.27M | -40.27%14.45M | -36.34%18.51M | -46.49%20.79M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -28.90%406K | -28.90%406K | -57.83%609K | -79.73%256K | -78.71%635K | -64.42%571K | -64.42%571K | 7.92%1.44M | -49.76%1.26M | -34.56%2.98M |
| -accounts payable | -28.90%406K | -28.90%406K | -57.83%609K | -79.73%256K | -78.71%635K | -64.42%571K | -64.42%571K | 7.92%1.44M | -49.76%1.26M | -34.56%2.98M |
| Current accrued expenses | --0 | --0 | 223.56%1.13M | 18.02%655K | -24.06%707K | -10.82%1.14M | -10.82%1.14M | -77.61%348K | -82.34%555K | -76.58%931K |
| Current debt and capital lease obligation | ---- | ---- | ---- | -47.22%19K | -47.17%28K | -28.99%49K | -28.99%49K | -67.27%18K | -28.00%36K | -67.48%53K |
| -Current capital lease obligation | --0 | --0 | --0 | -47.22%19K | -47.17%28K | -28.99%49K | -28.99%49K | -67.27%18K | -28.00%36K | 1.92%53K |
| Current liabilities | -46.18%1.66M | -46.18%1.66M | -34.62%2.11M | -35.54%1.85M | -55.68%2.1M | -36.03%3.08M | -36.03%3.08M | -23.27%3.22M | -57.06%2.87M | -49.46%4.74M |
| Non current liabilities | ||||||||||
| Preferred securities outside stock equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -46.18%1.66M | -46.18%1.66M | -34.62%2.11M | -35.54%1.85M | -55.68%2.1M | -36.03%3.08M | -36.03%3.08M | -23.60%3.22M | -57.29%2.87M | -51.16%4.74M |
| Shareholders'equity | ||||||||||
| Share capital | 100.00%60K | 100.00%60K | 96.67%59K | -95.13%59K | -95.06%59K | 11.11%30K | 11.11%30K | -96.62%30K | 68.43%1.21M | 77.68%1.19M |
| -common stock | 100.00%60K | 100.00%60K | 96.67%59K | -95.13%59K | -95.06%59K | 11.11%30K | 11.11%30K | -96.62%30K | 68.43%1.21M | 77.68%1.19M |
| Retained earnings | -3.42%-172.16M | -3.42%-172.16M | -5.55%-170.93M | -10.97%-173.03M | -10.32%-170.75M | -14.52%-166.47M | -14.52%-166.47M | -16.25%-161.94M | -23.70%-155.92M | -34.71%-154.78M |
| Paid-in capital | 4.84%182.03M | 4.84%182.03M | 5.01%181.82M | 6.23%180.96M | 6.44%180.55M | 1.99%173.63M | 1.99%173.63M | 9.32%173.14M | 15.35%170.35M | 18.32%169.63M |
| Total stockholders'equity | 38.03%9.93M | 38.03%9.93M | -2.44%10.95M | -48.89%7.99M | -38.52%9.87M | -71.12%7.19M | -71.12%7.19M | -43.80%11.22M | -30.05%15.64M | -44.94%16.05M |
| Total equity | 38.03%9.93M | 38.03%9.93M | -2.44%10.95M | -48.89%7.99M | -38.52%9.87M | -71.12%7.19M | -71.12%7.19M | -43.80%11.22M | -30.05%15.64M | -44.94%16.05M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg